Denali (DNLI) Tezkor likvidlik koeffitsiyenti
Denali Therapeutics (DNLI) rahbariyatining neyrobiologiya sohasidagi yuqori ekspertizasi GURU.Markets servisida tasdiqlangan bo'lib, u yerda kritik likvidlik koeffitsiyenti 8.34 metrik qiymatini qayd etdi. Denali Therapeutics (DNLI) o'zining kelgusi daromadlarini Altsgeymer va Parkinson kasalliklari uchun terapiyalarni ishlab chiqishga asoslaydi. Biroq, qimmatga tushadigan tadqiqotlar va ishlanmalar tufayli joriy moliyaviy holati zaxiralarning kamayishi va tashqi kapitalga bog'liqlik bilan tavsiflanadi.
%20Shoshilinch%20likvidlik%20koeffitsiyenti&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_DNLI_-_Denali-Therapeutics_-_Immediate-Liquidity-Ratio "DNLI: Denali Therapeutics Tezkor likvidlik koeffitsiyenti 04.07.2022 - 29.10.2026 | 👁️GURU.Markets👁️")
DNLI (denalitherapeutics.com): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi tafsilotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Denali Therapeutics|DNLI - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics Inc.|DNLI - Kompaniya qarzlari|Balans kapitallashuviga qarzlar Denali Therapeutics Inc|DNLI - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli majburiyatlari Denali Therapeutics|Tezkor likvidlik ko‘rsatkichi denalitherapeutics.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Fundamental baholash:Denali Therapeutics Inc - DNLI
Denali Therapeutics kompaniyasining qon-miya to'sig'ini yengish borasidagi murakkab ishlanmalari ulkan xarajatlarni talab qiladi, bu esa mavjud naqd mablag'lar monitoringini o'ta muhim qiladi. Tezkor koeffitsientni tahlil qilish orqali investor illikvid aktivlarni chiqarib tashlagan holda, kompaniyaning qisqa muddatli majburiyatlarini faqat naqd pul va debitorlik qarzlari hisobiga qoplash qobiliyatini baholaydi hamda biznesning real moliyaviy barqarorlik zaxirasini aniqlaydi.
Denali Therapeutics (DNLI) raqobatchilari
Biogen Corp (BIIB) - Tezkor likvidlik|Shoshilinch likvidlik Neurocrine Corp (NBIX)|RGC (Regencell Bioscience) - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik koeffitsiyenti AXSM (axsome.com)|Tezkor likvidlik koeffitsiyenti ACAD|XENE - Shoshilinch likvidlik|Tezkor likvidlik Viking Pharma VKTX|SUPN: Shoshilinch likvidlik koeffitsiyenti|Catalyst Pharmaceuticals - Tezkor likvidlik koeffitsiyenti|HRMY - Tezkor likvidlik koeffitsiyenti|Biohaven (BHVN) - Tezkor likvidlik|AMLX (Amylyx Pharmaceuticals Inc) - Tezkor likvidlik|TRVI (Trevi Pharma) - Tezkor likvidlik koeffitsiyenti|Praxis Corp (PRAX) - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi AVXL (Anavex Life Sciences)|CBLL (ceribell.com) - Oraliq qoplash koeffitsiyenti|Prothena Corporation PLC - Tezkor likvidlik ko‘rsatkichi|Oraliq likvidlik koeffitsiyenti ALEC (Alector Inc.)|Annexon Inc. - Tezkor likvidlik koeffitsiyenti|Oraliq qoplash koeffitsiyenti OMER (Omeros Corporation)|NGNE: Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik acimmune.com (ACIU)|Tezkor likvidlik Voyager Therapeutics, Inc.|NMRA: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti SCLX|Tezkor likvidlik koeffitsiyenti Tevogen Bio Inc. (TVGN)|Tezkor likvidlik Alpha Cognition Inc. ACOG|CGTX (Cognition Therapeutics Inc.) - Kritik likvidlik koeffitsiyenti|Inhibikase Therapeutics, Inc. - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Cassava Sciences Inc|ASRT (assertiotx.com) - Tezkor likvidlik ko‘rsatkichi|Coya Therapeutics (COYA) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi VTGN|OVID (Ovid Rx) - Oraliq likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti ABOS|Oraliq qoplama koeffitsiyenti CervoMed, Inc.|Tezkor likvidlik koeffitsiyenti ATHE (Alterity Therapeutics Limited)|CLNN - Tezkor likvidlik ko‘rsatkichi|PEPG - Tezkor likvidlik|Oraliq qoplama koeffitsiyenti Jupiter Neurosciences, Inc. JUNS|RLMD: Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik koeffitsiyenti ANVS|Tezkor likvidlik Grace Therapeutics Inc|Shoshilinch likvidlik koeffitsiyenti AIFF (Firefly Neuro)|Tezkor likvidlik Klotho Neurosciences Inc (KLTO)|Tezkor likvidlik NRSN (neurosense-tx.com)|Tezkor likvidlik koeffitsiyenti RVPH (Reviva Pharmaceuticals Holdings, Inc.)|Oraliq qoplama koeffitsiyenti MetaVia Inc. (MTVA)|NRXS - Tezkor likvidlik|HSDT (Helius Medical) - Shoshilinch likvidlik koeffitsiyenti|PASG: Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Neuphoria Therapeutics (NEUP)|Tezkor likvidlik ko‘rsatkichi NERV|Tezkor likvidlik koeffitsiyenti Athira Pharma Inc|Tezkor likvidlik Addex Therapeutics, Ltd. (ADXN)|ALZN (alzamend.com) - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Cyclerion Therapeutics, Inc. CYCN|Protagenic Therapeutics Inc. (PTIX) - Shoshilinch likvidlik|Pasithea - Tezkor likvidlik koeffitsiyenti|CRGT (Cortigent, Inc.) - Shoshilinch likvidlik koeffitsiyenti|ATXI: Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik BrainStorm Cell Therapeutics Inc. (BCLI)|Tezkor likvidlik Cara Therapeutics, Inc.|Shoshilinch likvidlik koeffitsiyenti CHRO (chromocell.com)|Tezkor likvidlik koeffitsiyenti ELYM|Tezkor likvidlik koeffitsiyenti intracellulartherapies.com (ITCI)|Tezkor likvidlik Longboard Pharma LBPH|Marinus Pharma - Tezkor likvidlik|NKGen Biotech, Inc. - Tezkor likvidlik koeffitsiyenti|Oraliq qoplama koeffitsiyenti neurobopharma.com NRBO|SAGE (Sage Therapeutics) - Tezkor likvidlik ko‘rsatkichi|Synaptogenix Inc. - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi TRVN|VIGL (Vigil Neuro) - Oraliq likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti WENA|CERE (cerevel.com) - Oraliq qoplash koeffitsiyenti